HPLC-MS Method for Analysis of Cariprazine on Primesep B Column

Separation type: Liquid Chromatography Mixed-mode SIELC Technologies

Cariprazine is an atypical antipsychotic medication primarily used to treat psychiatric disorders such as schizophrenia and bipolar disorder. It is a dopamine D2/D3 receptor partial agonist , with a preference for the D3 receptor, which helps modulate neurotransmitter activity in the brain. This unique mechanism makes it effective in managing symptoms like hallucinations, delusions, and mood swings.

Brand name : Vraylar (most common)

Cariprazine has shown efficacy in treating both the positive (hallucinations, delusions) and negative (social withdrawal, lack of motivation) symptoms of schizophrenia. Its partial agonist effect at D3 receptors may help reduce the risk of some side effects seen with other antipsychotics, such as weight gain or sedation.

Cariprazine can be retained, separated and analyzed using a Primesep B mixed-mode stationary phase column. The analysis employs a gradient method with a simple mobile phase comprising water, acetonitrile (MeCN), and formic acid as a buffer. This method allows for detection using UV 260 nm.

You can find detailed UV spectra of Cariprazine and information about its various lambda maxima by visiting the following link .